neurological disorders

VANCOUVER, Canada — December 12, 2025 — NervGen Pharma Corp., a clinical-stage biopharmaceutical company developing regenerative therapies for neurological...

CAMBRIDGE, Mass., Sept. 30, 2025 — Clear Scientific, Inc. announced that the U.S. Food and Drug Administration (FDA) has...

September 18, 2025 — Cambridge, Massachusetts Biogen has announced the acquisition of Alcyone Therapeutics, a Massachusetts-based biotech company specializing...